Trinity Biotech (TRIB) Construction in Progress (2016 - 2018)

Trinity Biotech's Construction in Progress history runs 3 years deep, the most recent figure standing at $204000.0 for Q4 2018.

• In Q4 2018, Construction in Progress fell 63.64% year-over-year to $204000.0; the TTM figure through Dec 2018 stood at $204000.0 (down 63.64% YoY), while the FY2018 annual figure was $204000.0, down 63.64% from the prior year.
• Construction in Progress came in at $204000.0 for Q4 2018 at Trinity Biotech, down from $561000.0 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $778000.0 in Q4 2016 to a low of $204000.0 in Q4 2018.
• A 3-year average of $514333.3 and a median of $561000.0 in 2017 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress decreased 27.89% in 2017 and sank 63.64% in 2018, its largest moves.
• Trinity Biotech's Construction in Progress stood at $778000.0 in 2016, then decreased by 27.89% to $561000.0 in 2017, then tumbled by 63.64% to $204000.0 in 2018.
• According to Business Quant data, Construction in Progress over the past three periods registered $204000.0, $561000.0, and $778000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.

Peer Comparison